Artwork for podcast Pathfinders in Biopharma
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point?
Episode 8 • 2nd June 2023 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:17:03

Share Episode

Shownotes

In the latest episode of Pathfinders, Senior Biotechnology Analyst Gregory Renza discusses what’s driving the latest spate of biotech M&A activity — the new players and partnership dynamics that are creating what he calls “a landscape of competition” in the broader market.

Follow

Links

Chapters

Video

More from YouTube